Literature DB >> 26753692

Increased mortality and aggravation of heart failure in liver X receptor-α knockout mice after myocardial infarction.

Xiaoqiang Liu1, Jianshu Gao2, Qiang Xia3, Tianfei Lu3, Fang Wang4.   

Abstract

Liver X receptors, LXRα (NR1H3) and LXRβ (NR1H2), are best known as nuclear oxysterol receptors and physiological master regulators of lipid and cholesterol metabolism. LXRα play a protective role in acute myocardial ischemia/reperfusion (MI/R) injury, but its role in myocardial infarction (MI) is unknown. The present study was undertaken to determine the effect of LXRα knockout on survival and development of chronic heart failure after MI. Wild-type (WT) and LXRα(-/-) mice were subjected to MI followed by serial echocardiographic and histological assessments. Greater myocyte apoptosis and inflammation within the infarcted zones were found in LXRα(-/-) group at 3 days after MI. At 4 weeks post-MI, LXRα(-/-) MI murine hearts demonstrated significantly increased infarct size, reduced ejection fraction (LXRα(-/-) 29.4 % versus WT 34.4 %), aggravated left ventricular (LV) chamber dilation, enhanced fibrosis and reduced angiogenesis. In addition, LXRα(-/-) mice had increased mortality compared with WT mice. LXRα deficiency increases mortality, aggravates pathological injury and LV remodeling induced by MI. Drugs specifically targeting LXRα may be promising in the treatment of MI.

Entities:  

Keywords:  Apoptosis; Heart failure; Mortality; Myocardial infarction; Nuclear receptors

Mesh:

Substances:

Year:  2016        PMID: 26753692     DOI: 10.1007/s00380-015-0781-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  36 in total

Review 1.  Electrophysiological remodeling in hypertrophy and heart failure.

Authors:  G F Tomaselli; E Marbán
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

2.  Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.

Authors:  Kang He; Xiaosong Chen; Conghui Han; Longmei Xu; Jianjun Zhang; Ming Zhang; Qiang Xia
Journal:  Kidney Int       Date:  2013-09-11       Impact factor: 10.612

3.  Activation of liver-X-receptor α but not liver-X-receptor β protects against myocardial ischemia/reperfusion injury.

Authors:  Qing He; Jun Pu; Ancai Yuan; Wayne Bond Lau; Erhe Gao; Walter J Koch; Xin-Liang Ma; Ben He
Journal:  Circ Heart Fail       Date:  2014-10-02       Impact factor: 8.790

Review 4.  Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.

Authors:  Anna Ahn; William H Frishman; Andrew Gutwein; Jonathan Passeri; Michael Nelson
Journal:  Cardiol Rev       Date:  2008 Jul-Aug       Impact factor: 2.644

5.  Early anti-apoptosis treatment reduces myocardial infarct size after a prolonged reperfusion.

Authors:  F Gao; L Tao; W Yan; E Gao; H-R Liu; B L Lopez; T A Christopher; X L Ma
Journal:  Apoptosis       Date:  2004-09       Impact factor: 4.677

6.  Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

Authors:  Ramón Martos; John Baugh; Mark Ledwidge; Christina O'Loughlin; Carmel Conlon; Anil Patle; Seamas C Donnelly; Kenneth McDonald
Journal:  Circulation       Date:  2007-02-05       Impact factor: 29.690

7.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

Review 8.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

9.  Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction.

Authors:  Manuela Cabiati; Alessandro Martino; Letizia Mattii; Chiara Caselli; Tommaso Prescimone; Vincenzo Lionetti; Maria-Aurora Morales; Silvia Del Ry
Journal:  Heart Vessels       Date:  2013-07-11       Impact factor: 2.037

10.  LXR as a novel antithrombotic target.

Authors:  Michael Spyridon; Leonardo A Moraes; Chris I Jones; Tanya Sage; Parvathy Sasikumar; Giovanna Bucci; Jonathan M Gibbins
Journal:  Blood       Date:  2011-03-16       Impact factor: 22.113

View more
  3 in total

1.  Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.

Authors:  Chunmei Li; Rui Han; Le Kang; Jianping Wang; Yonglin Gao; Yanshen Li; Jie He; Jingwei Tian
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

2.  Farnesoid X receptor deletion improves cardiac function, structure and remodeling following myocardial infarction in mice.

Authors:  Jianshu Gao; Xiaoqiang Liu; Bingjian Wang; Haiyan Xu; Qiang Xia; Tianfei Lu; Fang Wang
Journal:  Mol Med Rep       Date:  2017-05-29       Impact factor: 2.952

3.  ACE-inhibition induces a cardioprotective transcriptional response in the metabolic syndrome heart.

Authors:  Aziza Yakubova; Lieven Thorrez; Dmitry Svetlichnyy; Liesbeth Zwarts; Veerle Vulsteke; Griet Laenen; Wouter Oosterlinck; Yves Moreau; Luc Dehaspe; Jeroen Van Houdt; Álvaro Cortés-Calabuig; Bart De Moor; Patrick Callaerts; Paul Herijgers
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.